BioLife Solutions, Inc. (BLFS)
BLFS Stock Price Chart
Explore BioLife Solutions, Inc. interactive price chart. Choose custom timeframes to analyze BLFS price movements and trends.
BLFS Company Profile
Discover essential business fundamentals and corporate details for BioLife Solutions, Inc. (BLFS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
22 Nov 1989
Employees
159.00
Website
https://www.biolifesolutions.comCEO
Roderick de Greef
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.
BLFS Financial Timeline
Browse a chronological timeline of BioLife Solutions, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.01.
Earnings released on 7 Aug 2025
EPS came in at -$0.33 falling short of the estimated -$0.02 by -1.56K%, while revenue for the quarter reached $25.42M , missing expectations by -1.05%.
Earnings released on 8 May 2025
EPS came in at $0.04 surpassing the estimated -$0.03 by +233.33%, while revenue for the quarter reached $23.94M , beating expectations by +7.74%.
Earnings released on 3 Mar 2025
EPS came in at -$0.01 surpassing the estimated -$0.06 by +83.33%, while revenue for the quarter reached -$3.42M , missing expectations by -115.69%.
Earnings released on 12 Nov 2024
EPS came in at -$0.02 surpassing the estimated -$0.09 by +77.78%, while revenue for the quarter reached $30.57M , beating expectations by +34.24%.
Earnings released on 8 Aug 2024
EPS came in at -$0.06 surpassing the estimated -$0.14 by +57.14%, while revenue for the quarter reached $28.33M , beating expectations by +18.28%.
Earnings released on 9 May 2024
EPS came in at -$0.19 surpassing the estimated -$0.26 by +26.92%, while revenue for the quarter reached $31.73M , beating expectations by +21.98%.
Earnings released on 29 Feb 2024
EPS came in at -$0.30 surpassing the estimated -$0.36 by +16.67%, while revenue for the quarter reached $32.73M , missing expectations by -2.00%.
Earnings released on 9 Nov 2023
EPS came in at -$0.67 falling short of the estimated -$0.38 by -76.32%, while revenue for the quarter reached $33.33M , missing expectations by -1.45%.
Earnings released on 8 Aug 2023
EPS came in at -$0.23 falling short of the estimated -$0.18 by -27.78%, while revenue for the quarter reached $39.51M , missing expectations by -9.92%.
Earnings released on 10 May 2023
EPS came in at -$0.32 falling short of the estimated -$0.20 by -60.00%, while revenue for the quarter reached $37.70M , missing expectations by -12.20%.
Earnings released on 16 Mar 2023
EPS came in at -$1.15 falling short of the estimated -$0.19 by -505.26%, while revenue for the quarter reached $44.26M , beating expectations by +2.26%.
Earnings released on 9 Nov 2022
EPS came in at -$0.23 falling short of the estimated -$0.18 by -27.78%, while revenue for the quarter reached $40.75M , missing expectations by -3.13%.
Earnings released on 9 Aug 2022
EPS came in at -$1.71 falling short of the estimated -$0.20 by -755.00%, while revenue for the quarter reached $40.53M , beating expectations by +3.48%.
Earnings released on 9 May 2022
EPS came in at -$0.17 surpassing the estimated -$0.24 by +29.17%, while revenue for the quarter reached $36.22M , missing expectations by -5.20%.
Earnings released on 28 Feb 2022
EPS came in at -$0.37 falling short of the estimated -$0.16 by -131.25%, while revenue for the quarter reached $37.30M , beating expectations by +4.16%.
Earnings released on 11 Nov 2021
EPS came in at $0.00 surpassing the estimated -$0.09 by +102.02%, while revenue for the quarter reached $33.80M , missing expectations by -90.34%.
Earnings released on 12 Aug 2021
EPS came in at $0.19 surpassing the estimated -$0.05 by +480.00%, while revenue for the quarter reached $31.20M , meeting expectations.
Earnings released on 13 May 2021
EPS came in at -$0.03 surpassing the estimated -$0.05 by +40.00%, while revenue for the quarter reached $16.85M , beating expectations by +4.97%.
Earnings released on 22 Mar 2021
EPS came in at -$0.06 matching the estimated -$0.06, while revenue for the quarter reached $14.73M .
Earnings released on 5 Nov 2020
EPS came in at -$0.04 falling short of the estimated -$0.01 by -336.21%, while revenue for the quarter reached $11.28M , beating expectations by +100.00%.
BLFS Stock Performance
Access detailed BLFS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.